Pfizer Inc. PFE NYSE

Pfizer Inc. (PFE) has shown declining revenue growth over the past 3 years, expanding from $100.3B to $62.6B (average -11.5%/yr). Net income reached $7.8B, reflecting exceptional earnings expansion at +60.8%/yr on average. The net profit margin is 12.4%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 70.3% (high), with a +4.5pp trend over the period. With a $154B market cap and MOAT composite score of 94/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (58/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 41-year history, the company was profitable in 41 of 41 years — a perfect long-term track record
• INCOME (55/100, Partial) — the company is profitable but margin is below 15%
• MOAT (94/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.